Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.
about
Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base.Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.The care center influences the management of lymphoma patients in a universal health care system: an observational cohort studyTime Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.Risk-adapted strategies for the treatment of Hodgkin lymphoma.Socioeconomic factors affect the selection of proton radiation therapy for children.Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials.Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis.Disparities in survival by insurance status in patients with Hodgkin lymphoma.What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?Health Insurance-Related Disparities in Lymphoma Survival Are Partly Mediated by Baseline Clinical Factors.Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
P2860
Q30978936-90D739AD-ED8C-40A9-B7F1-FB48079C7151Q31095966-CF10FF55-B256-4DAA-9AA7-08ACA4423B57Q31110269-2840E2BA-0E93-4B21-9A8C-84D039444714Q36093253-3F44BBD5-D887-479B-B648-6BED2C8714A4Q36117996-CEDCD254-59D7-426B-950B-8A96E0360887Q36369327-06760020-C9D6-467C-A516-2259E1E523A8Q36619445-4D53DB2E-C517-480F-8D37-DB4CAE2D7B26Q37014175-5F821A88-CCE6-4A90-B050-EA3DBE91F1D4Q38549745-9E355822-9B84-4017-9803-D187F7E4538DQ38591137-7BD0DAE0-25AA-4F41-9A18-FB64B0CDD71FQ38707143-BC2AEAC7-36BC-4FC4-A40C-88D5B622AF40Q38752787-6FC06944-B6F1-4849-B7C7-A04C8C643A04Q38773618-2CC2B3F2-2C36-455A-B1FF-4964CF1CBE29Q38852466-F685DC0A-DDCB-43EC-BCDE-2412FF694AE3Q40040274-13DD3B09-14E6-4977-A65A-34D726839CC5Q40476175-C775DD04-1BDB-4DF8-8817-388AB181BC92Q40853433-65D48AAF-35AB-411E-8475-A4DB454D989BQ40870346-DF482427-C734-458E-B26E-0FCB4E6C8536Q43234102-0AF32B3F-A986-4BFE-BB37-76AFB2F51924Q49932419-916E3430-395A-4B11-9442-A1C66146FC5CQ53011053-2F1C5399-D409-4E2B-B1AB-8060D774C4A2
P2860
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treatment selection and outcom ...... the National Cancer Data Base.
@ast
Treatment selection and outcom ...... the National Cancer Data Base.
@en
type
label
Treatment selection and outcom ...... the National Cancer Data Base.
@ast
Treatment selection and outcom ...... the National Cancer Data Base.
@en
prefLabel
Treatment selection and outcom ...... the National Cancer Data Base.
@ast
Treatment selection and outcom ...... the National Cancer Data Base.
@en
P356
P1476
Treatment selection and outcom ...... the National Cancer Data Base.
@en
P2093
Rajesh Shrestha
P304
P356
10.1200/JCO.2014.58.7543
P407
P577
2015-01-12T00:00:00Z